NCOA5 Haploinsufficiency in Myeloid-Lineage Cells Sufficiently Causes Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma

Cotter, 2020, Nonalcoholic fatty liver disease 2020: the state of the disease, Gastroenterology, 158, 1851, 10.1053/j.gastro.2020.01.052 Anstee, 2015, The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2, Semin Liver Dis, 35, 270, 10.1055/s-0035-1562947 Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, 24, 908, 10.1038/s41591-018-0104-9 Kazankov, 2019, The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Nat Rev Gastroenterol Hepatol, 16, 145, 10.1038/s41575-018-0082-x Gillespie, 2015, An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux, EMBO J, 34, 1244, 10.15252/embj.201489819 Jiang, 2004, TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription, J Biol Chem, 279, 27781, 10.1074/jbc.M401809200 Sauve, 2001, CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant, Mol Cell Biol, 21, 343, 10.1128/MCB.21.1.343-353.2001 Lewis, 2010, Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans, Genomics, 96, 211, 10.1016/j.ygeno.2010.07.006 Gao, 2013, NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma, Cancer Cell, 24, 725, 10.1016/j.ccr.2013.11.005 Williams, 2020, NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21(WAF1/CIP1) overexpression, which is reversed by metformin, Oncogene, 39, 3821, 10.1038/s41388-020-1256-x Abram, 2014, Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice, J Immunol Methods, 408, 89, 10.1016/j.jim.2014.05.009 Itoh, 2013, Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans, PLoS One, 8, 10.1371/journal.pone.0082163 Benhamed, 2012, The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J Clin Invest, 122, 2176, 10.1172/JCI41636 Foretz, 1999, Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes, Proc Natl Acad Sci U S A, 96, 12737, 10.1073/pnas.96.22.12737 Knebel, 2012, Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass, PLoS One, 7, 10.1371/journal.pone.0031812 Lee, 2018, Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2, Liver Res, 2, 209, 10.1016/j.livres.2018.12.001 Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485 Schmidt-Arras, 2016, IL-6 pathway in the liver: from physiopathology to therapy, J Hepatol, 64, 1403, 10.1016/j.jhep.2016.02.004 Zhang, 2016, CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy, J Hepatol, 64, 160, 10.1016/j.jhep.2015.09.005 Remmerie, 2020, Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver, Immunity, 53, 641, 10.1016/j.immuni.2020.08.004 Xiong, 2019, Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis, Mol Cell, 75, 644, 10.1016/j.molcel.2019.07.028 Barreby, 2019, Glucan-encapsulated siRNA particles (GeRPs) for specific gene silencing in adipose tissue macrophages, Methods Mol Biol, 1951, 49, 10.1007/978-1-4939-9130-3_4 Azzimato, 2020, Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance, Sci Transl Med, 12, 10.1126/scitranslmed.aaw9709 Morgantini, 2019, Liver macrophages regulate systemic metabolism through non-inflammatory factors, Nat Metab, 1, 445, 10.1038/s42255-019-0044-9 Luo, 2009, GAGE: generally applicable gene set enrichment for pathway analysis, BMC Bioinformatics, 10, 161, 10.1186/1471-2105-10-161 Arendt, 2015, Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids, Hepatology, 61, 1565, 10.1002/hep.27695 Barbie, 2009, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, 462, 108, 10.1038/nature08460 Rigamonti, 2008, Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men, Arterioscler Thromb Vasc Biol, 28, 1050, 10.1161/ATVBAHA.107.158998 Scheuerer, 2000, The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages, Blood, 95, 1158, 10.1182/blood.V95.4.1158.004k31_1158_1166 Drescher, 2019, Platelet factor 4 attenuates experimental acute liver injury in mice, Front Physiol, 10, 326, 10.3389/fphys.2019.00326 Gleissner, 2012, Macrophage phenotype modulation by CXCL4 in atherosclerosis, Front Physiol, 3, 1, 10.3389/fphys.2012.00001 Pan, 2020, Tumor-associated macrophages in tumor immunity, Front Immunol, 11, 10.3389/fimmu.2020.583084 Lin, 2019, Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications, J Hematol Oncol, 12, 76, 10.1186/s13045-019-0760-3 Fleischer, 2002, Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells, J Immunol, 169, 770, 10.4049/jimmunol.169.2.770 Liu, 2005, Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells, J Immunol, 174, 2680, 10.4049/jimmunol.174.5.2680 Joseph, 2021, CD8(+) T cells inhibit metastasis and CXCL4 regulates its function, Br J Cancer, 125, 176, 10.1038/s41416-021-01338-5 Newman, 2019, Determining cell type abundance and expression from bulk tissues with digital cytometry, Nat Biotechnol, 37, 773, 10.1038/s41587-019-0114-2 Aran, 2017, xCell: digitally portraying the tissue cellular heterogeneity landscape, Genome Biol, 18, 220, 10.1186/s13059-017-1349-1 Alshetaiwi, 2020, Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics, Sci Immunol, 5, 10.1126/sciimmunol.aay6017 Zheng, 2017, Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing, Cell, 169, 1342, 10.1016/j.cell.2017.05.035 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102 Roessler, 2010, A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients, Cancer Res, 70, 10202, 10.1158/0008-5472.CAN-10-2607 Gao, 2019, Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma, Cell, 179, 561, 10.1016/j.cell.2019.08.052 Hansen, 2017, Mouse models of nonalcoholic steatohepatitis in preclinical drug development, Drug Discov Today, 22, 1707, 10.1016/j.drudis.2017.06.007 Farrell, 2019, Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis, Hepatology, 69, 2241, 10.1002/hep.30333 Zhong, 2020, Rodent models of nonalcoholic fatty liver disease, Digestion, 101, 522, 10.1159/000501851 Carter-Kent, 2008, Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment, Am J Gastroenterol, 103, 1036, 10.1111/j.1572-0241.2007.01709.x Fuentes, 2010, Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages, Mediators Inflamm, 2010, 10.1155/2010/219583 Roberts, 2015, Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats, BMC Gastroenterol, 15, 151, 10.1186/s12876-015-0382-3 Dominguez, 2009, Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis, Gastroenterology, 136, 1639, 10.1053/j.gastro.2009.01.056 Zaldivar, 2010, CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis, Hepatology, 51, 1345, 10.1002/hep.23435 Pertuy, 2015, Broader expression of the mouse platelet factor 4-cre transgene beyond the megakaryocyte lineage, J Thromb Haemost, 13, 115, 10.1111/jth.12784 Gray, 2023, Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors, Cell Rep, 42, 10.1016/j.celrep.2022.111930 Deiuliis, 2014, CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance, Obesity (Silver Spring), 22, 1264, 10.1002/oby.20642 Lasagni, 2003, An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4, J Exp Med, 197, 1537, 10.1084/jem.20021897 Tan, 2020, Platelet factor 4 enhances CD4(+) T effector memory cell responses via Akt-PGC1alpha-TFAM signaling-mediated mitochondrial biogenesis, J Thromb Haemost, 18, 2685, 10.1111/jth.15005 Willox, 2010, Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells, Mol Immunol, 47, 2367, 10.1016/j.molimm.2010.05.005 Xu, 2020, Angptl7 promotes insulin resistance and type 2 diabetes mellitus by multiple mechanisms including SOCS3-mediated IRS1 degradation, FASEB J, 34, 13548, 10.1096/fj.202000246RR Banini, 2021, NAFLD-related HCC, Adv Cancer Res, 149, 143, 10.1016/bs.acr.2020.11.001 Peiseler, 2021, Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma, Cancers (Basel), 13, 10.3390/cancers13040730 Karin, 2018, New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance, Precis Clin Med, 1, 21, 10.1093/pcmedi/pby005 Gleissner, 2010, CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages, J Immunol, 184, 4810, 10.4049/jimmunol.0901368 Ruytinx, 2018, Chemokine-induced macrophage polarization in inflammatory conditions, Front Immunol, 9, 1930, 10.3389/fimmu.2018.01930 Ruytinx, 2018, CXCL4 and CXCL4L1 in cancer, Cytokine, 109, 65, 10.1016/j.cyto.2018.02.022 Mehlem, 2013, Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease, Nat Protoc, 8, 1149, 10.1038/nprot.2013.055 Junqueira, 1979, Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections, Histochem J, 11, 447, 10.1007/BF01002772 Ran, 2013, Genome engineering using the CRISPR-Cas9 system, Nat Protoc, 8, 2281, 10.1038/nprot.2013.143 Charni-Natan, 2020, Protocol for primary mouse hepatocyte isolation, STAR Protoc, 1 Chen, 2018, fastp: an ultra-fast all-in-one FASTQ preprocessor, Bioinformatics, 34, i884, 10.1093/bioinformatics/bty560 Patro, 2017, Salmon provides fast and bias-aware quantification of transcript expression, Nat Methods, 14, 417, 10.1038/nmeth.4197 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 550, 10.1186/s13059-014-0550-8 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 Ritchie, 2015, limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res, 43, e47, 10.1093/nar/gkv007 Steen, 2020, Profiling cell type abundance and expression in bulk tissues with CIBERSORTx, Methods Mol Biol, 2117, 135, 10.1007/978-1-0716-0301-7_7 Chen, 2017, Inference of immune cell composition on the expression profiles of mouse tissue, Sci Rep, 7